日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy

新辅助化疗免疫疗法治疗IIIA期非小细胞肺癌患者的肿瘤免疫动力学和长期临床结果

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-63696-5
Schmid, Dominic; Sobottka, Bettina; Manzo, Massimiliano; Trüb, Marta; Leonards, Katharina; Herzig, Petra; Oyewole, Oluwaseun Rume-Abiola; Jermann, Philip; Hayoz, Stefanie; Savic Prince, Spasenija; Tochtermann, Giulia; Natoli, Marina; Pless, Miklos; Bettini, Adrienne; Früh, Martin; Mauti, Laetitia A; Britschgi, Christian; Peters, Solange; Mark, Michael; Ochsenbein, Adrian F; Janthur, Wolf-Dieter; Waibel, Christine; Mach, Nicolas; Froesch, Patrizia; Buess, Martin; Bohanes, Pierre; Gonzalez, Michel; Alborelli, Ilaria; Rothschild, Sacha I; Koelzer, Viktor Hendrik; Zippelius, Alfred
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

A Real-World Experience on the Efficacy of First-Line Treatment with Immune-Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Patients with PD-L1 Expression ≥50%: The Role of KRAS Mutations

一项关于免疫检查点抑制剂一线治疗PD-L1表达≥50%的非小细胞肺癌患者疗效的真实世界研究：KRAS突变的作用

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17243980
Motta, Lucia; Epistolio, Samantha; Pankovics, Jana; Molinari, Francesca; Pedrazzini, Benjamin; Valera, Alexandra; Giudici, Luca; Freguia, Stefania; Patella, Miriam; Imbimbo, Martina; Schiavone, Giovanna; Frattini, Milo; Froesch, Patrizia
Checkpoint
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
RAS
免疫/内分泌
发表日期：2025
文献求助 收藏

First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study

小细胞肺癌一线化疗联合免疫疗法：一项双边真实世界研究的结果

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2024.100744
Moliner, Laura; Zellweger, Núria; Schmid, Sabine; Bertschinger, Martina; Waibel, Christine; Cerciello, Ferdinando; Froesch, Patrizia; Mark, Michael; Bettini, Adrienne; Häuptle, Pirmin; Blum, Veronika; Holer, Lisa; Hayoz, Stefanie; Früh, Martin; Ahmed, Samreen; Bhagani, Shradha; Steele, Nicola; Gray, Hannah-Leigh; Robinson, Stephen D; Davidson, Michael; Cox, Samantha; Khalid, Taha; Geldart, Tom R; Nolan, Luke; Scott, Deborah C; Hennah, Lindsay; Newsom-Davis, Tom; Rathbone, Emma; Handforth, Catherine; Denton, Arshi; Merchant, Shairoz; Blackhall, Fiona; Mauti, Laetitia A; Califano, Raffaele; Rothschild, Sacha I
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Prognostic Impact of KRAS-TP53 Co-Mutations in Patients with Early-Stage Non-Small Cell Lung Cancer: A Single-Center Retrospective Study

KRAS-TP53共突变对早期非小细胞肺癌患者预后的影响：一项单中心回顾性研究

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14145135
Motta, Lucia; Molinari, Francesca; Pankovics, Jana; Pedrazzini, Benjamin; Valera, Alexandra; Epistolio, Samantha; Giudici, Luca; Freguia, Stefania; Patella, Miriam; Imbimbo, Martina; Schiavone, Giovanna; Frattini, Milo; Froesch, Patrizia
肺癌
肿瘤
肿瘤免疫
P53
细胞生物学
RAS
发表日期：2025
文献求助 收藏

Place in therapy of key treatments for platinum-sensitive, relapsed, extensive-stage small cell lung cancer with a focus on lurbinectedin: a narrative review with case studies

铂敏感、复发、广泛期小细胞肺癌关键治疗方案中的地位，以鲁比替丁为重点：病例研究叙述性综述

期刊:Drugs in Context
影响因子:2.8
doi:10.7573/dic.2025-7-9
Shunyakov, Leonid; Badin, Firas B; Hafer, Judith; König, David; Froesch, Patrizia; Greillier, Laurent
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment

接受伊匹木单抗联合纳武利尤单抗一线或二线治疗的恶性胸膜间皮瘤患者的真实世界疗效

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2024.100735
Schmid, Sabine; Holer, Lisa; Gysel, Katrin; Koster, Kira-Lee; Rothschild, Sacha I; Boos, Laura A; Frehner, Lorenz; Cardoso Almeida, Sabine; Britschgi, Christian; Metaxas, Yannis; Mark, Michael; Froesch, Patrizia; Janthur, Wolf-Dieter; Allemann, Anna; Waibel, Christine; Von der Mühll-Schill, Catherine; Früh, Martin; Mauti, Laetitia A
发表日期：2024
文献求助 收藏

Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study

lurbinectedin 作为进行性恶性胸膜间皮瘤 (MPM) 姑息化疗的长期益处：SAKK 17/16 研究的最终疗效和转化数据

期刊:ESMO Open
影响因子:7.1
doi:10.1016/j.esmoop.2022.100446
M Mark, S Rusakiewicz, M Früh, S Hayoz, F Grosso, M Pless, P Zucali, G L Ceresoli, A Maconi, M Schneider, P Froesch, D Tarussio, F Benedetti, J Dagher, L Kandalaft, R von Moos, S Tissot-Renaud, S Schmid, Y Metaxas
肿瘤
发表日期：2022
文献求助 收藏

Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers

K-Ras突变型非小细胞肺癌的分子生物学和治疗前景

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14174103
Cekani, Elona; Epistolio, Samantha; Dazio, Giulia; Cefalì, Marco; Wannesson, Luciano; Frattini, Milo; Froesch, Patrizia
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2

SAKK 19/17：对PD-L1阳性、晚期非小细胞肺癌且体能状态评分为2的患者进行一线度伐利尤单抗治疗的安全性分析

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-020-02757-8
Mark, Michael; Froesch, Patrizia; Eboulet, Eric Innocents; Addeo, Alfredo; Pless, Miklos; Rothschild, Sacha I; Janthur, Wolf-Dieter; Burmeister, Henning; Friedlaender, Alex; Schneider, Martina; Metaxas, Yannis; Joerger, Markus; Wannesson, Luciano; Schwitter, Michael; Baudoux, Nathalie; Weindler, Susanne; Biaggi-Rudolf, Christine; Früh, Martin
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
发表日期：2021
文献求助 收藏

Overview of recent advances in molecular analysis for diagnosing early stage lung cancer nodules

概述分子分析在早期肺癌结节诊断中的最新进展

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-21-802
Frattini, Milo; Froesch, Patrizia; Epistolio, Samantha
肺癌
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏